Embecta Corp. (NASDAQ:EMBC) posted on Friday the second-quarter 2025 adjusted earnings of 70 cents per share, up from 67 ...

Q1 2025 Earnings Call Transcript May 6, 2025 AdaptHealth Corp. reports earnings inline with expectations. Reported EPS is ...

Reduced debt during the fiscal year 2025 second quarter by paying down approximately $27.4 million of outstanding principal ...

Embecta now expects revenues between $1.073 billion and $1.09 billion. This would mark a sales dip of between 4.4% and 2.9% ...

Over the years, dividend-paying stocks have become increasingly popular as investors lean toward income-focused investment ...

NEW YORK - Embecta Corp. (NASDAQ: EMBC) reported better-than-expected second quarter results on Friday, as the diabetes care company beat analyst estimates for both earnings and r ...

Q2 2025 Earnings Conference Call May 9, 2025 8:00 AM ETCompany ParticipantsDev Kurdikar - President & CEOJake Elguicze ...

Direct-to-store model (delivering drugs directly to each retailer’s stores) of distributors are increasingly becoming more popular among retailers (represents 93% of sales in 2017, up from 74% in 2007 ...

Q3 2025 Earnings Call Transcript May 7, 2025 Bio-Techne Corporation beats earnings expectations. Reported EPS is $0.56, ...

The Global Hydrogel Dressing Market has demonstrated significant growth and potential in the realm of medical dressings, with its valuation standing at $320.85 million in 2019. This market is ...

Detailed price information for Amarin Corp ADR (AMRN-Q) from The Globe and Mail including charting and trades.